FDA Approves Pfizer's and Eisai's FRAGMIN(R) as First Low-Molecular-Weight Heparin for Extended Treatment to Reduce the Recurrence of Blood Clots in Patients with Cancer WOODCLIFF LAKE, N.J. and NEW ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback